Detalles de la búsqueda
1.
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.
Brain Behav Immun
; 111: 211-229, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990297
2.
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression.
Bipolar Disord
; 25(2): 99-109, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36516343
3.
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis.
Brain Behav Immun
; 101: 93-135, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973396
4.
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?
J Sleep Res
; 31(1): e13400, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34137095
5.
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.
CNS Spectr
; 27(3): 322-330, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33267928
6.
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation.
CNS Spectr
; 27(3): 315-321, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33298225
7.
The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset.
CNS Spectr
; 27(3): 378-382, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461640
8.
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
Am J Geriatr Psychiatry
; 29(9): 899-913, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33478865
9.
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.
Bipolar Disord
; 22(8): 831-840, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406161
10.
Corrigendum to "COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis" [Brain Behav. Immun. 111 (2023) 211-229].
Brain Behav Immun
; 115: 758, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806865
11.
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.
J Psychopharmacol
; 38(4): 375-381, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477185
12.
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.
J Psychopharmacol
; 37(8): 775-783, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37194253
13.
Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity.
Psychiatry Res Neuroimaging
; 329: 111592, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708594
14.
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression.
Focus (Am Psychiatr Publ)
; 21(4): 420-429, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38694999
15.
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.
Psychiatry Res
; 323: 115133, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889160
16.
Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review.
Psychiatry Res
; 312: 114579, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504148
17.
The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.
Psychiatry Res
; 313: 114577, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580433
18.
Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence.
Psychiatry Res
; 307: 114321, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890909
19.
The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression.
J Affect Disord
; 300: 219-225, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952118
20.
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review.
J Affect Disord
; 318: 139-149, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049604